HF
CRL icon

Hoxton Financial’s Charles River Laboratories CRL Stock Holding History

Hoxton Financial’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-159
Closed -$8K – 383
2013
Q4 		$8K Buy
159
+43
+37% +$2.16K ﹤0.01% 478
2013
Q3 		$5K Sell
116
-2
-2% -$92 ﹤0.01% 330
2013
Q2 		$5K Buy
+118
New +$5.06K ﹤0.01% 493

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Hoxton Financial's CRL Position: Q1 2014 in Review

Hoxton Financial sold out of Charles River Laboratories (CRL) in Q1 2014, closing a stake of 159 shares — an estimated $8K sold.

Hoxton Financial first reported a position in CRL in Q2 2013 and held it in 3 quarters. The position peaked at $8K in Q4 2013. 258 funds tracked by Wall St. Rank hold CRL as of Q1 2014.

  • Hoxton Financial reported no remaining Charles River Laboratories position as of Q1 2014 after selling out during the quarter.
  • Hoxton Financial sold 159 Charles River Laboratories shares in Q1 2014, an estimated $8K.
  • Hoxton Financial first reported a position in Charles River Laboratories in Q2 2013 and held it in 3 quarters.
  • Hoxton Financial's Charles River Laboratories position peaked at $8K in Q4 2013.
  • 258 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2014.

Based on Hoxton Financial's 13F filing for Q1 2014, filed 25 Apr 2014.